Literature DB >> 7661926

Circulating interleukin-6 receptor in patients with sepsis syndrome.

J T Frieling1, M van Deuren, J Wijdenes, J W van der Meer, C Clement, C J van der Linden, R W Sauerwein.   

Abstract

Concentrations of interleukin (IL)-6, soluble IL-6 receptor (sIL-6R), and soluble tumor necrosis factor receptor (sTNFR) p55 and p75 were measured in 25 patients with sepsis syndrome. Sequential blood samples were drawn from patients during a 7-h period. IL-6 concentrations were 34-763,000 pg/mL; they were higher in nonsurvivors than survivors, but the difference was not statistically significant. In septic patients, the median sIL-6R concentration was significantly lower than in 19 healthy volunteers (43 vs. 80 ng/mL). sIL-6R concentrations in survivors were not significantly different than those in nonsurvivors. There was a negative correlation between IL-6 and sIL-6R in septic patients (r = -.72). In patients with moderately impaired renal function, sIL-6R levels were not affected, but the concentrations of sTNFRs were significantly higher.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7661926     DOI: 10.1093/infdis/171.2.469

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Construction and characterization of a replication-deficient adenovirus expressing rat-soluble interleukin-6 receptor.

Authors:  V Thibault; B Terlain; F L Graham; J Gauldie
Journal:  Mol Med       Date:  1997-08       Impact factor: 6.354

2.  Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment.

Authors:  J T Frieling; J A Mulder; T Hendriks; J H Curfs; C J van der Linden; R W Sauerwein
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.

Authors:  Paul Baran; Selina Hansen; Georg H Waetzig; Mohammad Akbarzadeh; Larissa Lamertz; Heinrich J Huber; M Reza Ahmadian; Jens M Moll; Jürgen Scheller
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

4.  IL6 trans-signaling promotes functional recovery of hypofunctional phagocytes through STAT3 activation during peritonitis.

Authors:  Tsuyoshi Onogawa; Tatsuo Saito-Taki; Hiroshi Yamamoto; Takako Wada
Journal:  Inflamm Res       Date:  2013-06-04       Impact factor: 4.575

Review 5.  IL-6 in diabetes and cardiovascular complications.

Authors:  Dan Qu; Jian Liu; Chi Wai Lau; Yu Huang
Journal:  Br J Pharmacol       Date:  2014-08       Impact factor: 8.739

6.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

Authors:  M Peters; S Jacobs; M Ehlers; P Vollmer; J Müllberg; E Wolf; G Brem; K H Meyer zum Büschenfelde; S Rose-John
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

7.  Elevated levels of numerous cytokines in drainage fluid after primary total hip arthroplasty.

Authors:  Huub J L van der Heide; Peter M van der Kraan; Willard J Rijnberg; Pieter Buma; B Willem Schreurs
Journal:  Int Orthop       Date:  2009-08-21       Impact factor: 3.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.